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Study objectives: This study examined whether obstructive sleep apnoea syndrome (OSAS) is
associated with increased risk of work disability during six years following the diagnosis.
Design: Prospective follow-up study.
Setting: Ten municipalities and six hospital districts in Finland.
Participants: A total of 766 employees with OSAS (cases), and their control subjects
(nZ 3,827) matched for age, gender, socioeconomic position, type of employment contract
and type of organization.
Interventions: N/A.
Measurements: Data on all (>9 days) or very long-term (>90 days) sickness absences and for
disability pensions were obtained from national registers. Diagnosis of OSAS was determined
according to the Hospital Discharge Register, which includes data on all hospital admissions.
Results: According to the Cox proportional hazards models the hazard of the first sickness
absence period (all sickness absences) during the follow-up was 1.7-fold (95% confidence
interval (CI): 1.5e2.0) in male and 2.1-fold (95% CI: 1.8e2.4) in female sleep apnoea cases
compared to controls after adjustments for sociodemographic factors. Both men and women
with OSAS had a 2-fold increase in the risk for disability pension compared to controls. With
regard to cause-specific work disability, employees with OSAS had a particularly pronouncedby the Academy of Finland (project numbers 117 604, 124 271, 124 322, 129 262 and 126 602) and the
.
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1048 N. Sjo¨sten et al.risk of long-term work disability caused by injuries (HR 3.1 95% CI: 1.8e5.2) and mental disor-
ders (HR: 2.8, CI 95%: 2.1e3.7).
Conclusions: These results suggest that OSAS is associated with an increased risk of both sick-
ness absence and disability pension. They emphasize the need to identify the employees with
this disorder and to improve general practitioners’ knowledge about screening of sleep apnoea
symptoms and indicators.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Obstructive sleep apnoea syndrome (OSAS) is characterised
by recurrent complete or partial respiratory interruptions
during sleep, intermittent snoring, morning headaches, and
daytime sleepiness.1 It is a relatively common disorder,
with the prevalence estimates varying from 2% to 10%2e5
depending on the diagnostic criteria and the age of the
population (the risk of OSAS increases with age).3,6 OSAS
is associated with an increased risk of major car-
diovascular,7e9 psychiatric10 and metabolic11,12 morbidity
and increased mortality,13e15 especially when untreated.13
The economic and health care consequences of OSAS are
considerable.16,17 In the USA, for example, the estimated
health-related costs for untreated OSAS extend to US$ 3.4
billion per year.18 When appropriately treated, the costs
may be significantly reduced, even though they often still
remain at a higher level than in the general population.19
Although OSAS affects particularly working age pop-
ulation,20 the consequences of the disorder in terms of
temporary and permanent work disability are not well
understood. Previously, OSAS or symptoms of sleep apnoea
have been associated with an increased risk of occupational
accidents,21,22 decreased working ability and lower work
efficacy.23,24 In addition, people with OSAS have been found
to have more health care visits compared to con-
trols5,16,18,25e28 already years before the diagnosis.8,26,27 In
a recent study, self-reported symptoms of sleep apnoea
predicted long-term sick leave and permanent disability.29
However, we are not aware of any previous studies exam-
ining the risk of work disability in terms of sickness
absenteeism and work disability pension among persons
with a diagnosed OSAS.
The purpose of this register-based follow-up study was
to examine the association of diagnosed OSAS with subse-
quent medically certified sickness absence and disability
pension from all and specific causes among Finnish public
sector employees. Due to major comorbidity linked with
OSAS, chronic diseases such as cardiovascular diseases,
diabetes, asthma or other chronic obstructive lung diseases
and depression were taken into account in the analyses.
Methods
Study population and design
The datawere obtained from the Finnish Public Sector Study,
which is an ongoing prospective cohort study of Finnish
employees in the service of six hospital districts and 10
municipalities.30 For this study, we identified the eligible
population from the employers’ records, i.e., 151,618 publicsector employees who had been employed for at least six
months in any year between 1991 and 2005. Sickness absence
and disability pension data from national registers cover the
period between 1994 and 2005. To enable post-diagnosis
follow-up for each participant, only the persons getting
an OSAS diagnosis between 1994 and 2004 were initially
included (nZ 1073). Of these, persons who were 63 years or
older (nZ 68), had died (nZ 6), were granted disability
pension within the year subsequent to the OSAS diagnosis
(nZ 163), or were not employed by the participating
organizations within 3 years prior to the diagnosis (nZ 70)
were excluded leaving 766 cases in the analytic sample.
Five controls, matched for gender, age category (20e44,
45e54 or 55e62), socioeconomic position (SEP), type of
employment contract (permanent or fixed term) and type
of organization (hospital district or municipality), were
randomly selected for each sleep apnoea case from the
public sector employees not diagnosed with OSAS. For one
sleep apnoea case, only three control subjects fulfilling all
the predetermined criteria was found, so the final cohort
consisted of 766 employees with OSAS and 3827 controls.
The approval of the ethics committee of the Finnish
Institute of Occupational Health was obtained for the study.
Assessment of obstructive sleep apnoea syndrome
The participants’ personal identification numbers (a unique
number assigned to each Finnish citizen used for all
contacts with the social welfare and health care systems)
were used to link the participants to the national Hospital
Discharge Register kept by the National Research and
Development Centre for Health and Welfare (STAKES). The
Hospital Discharge Register gathers countrywide data on all
inpatient hospital admissions. For this study, we obtained
the admission dates for hospitalisation and diagnosis at
discharge. For all cases, OSAS was assigned by the treating
physician (codes 3472A and G47.3 in ICD-9 and ICD-10,31
respectively) at discharge between 1994 and 2004.
Assessment of sociodemographic and clinical
characteristics
The following sociodemographic characteristics were
derived from the employers’ records: gender, age, SEP
based on occupational title-based classification of Statistics
Finland, i.e., upper-grade non-manual workers (e.g.,
physicians, teachers), lower-grade non-manual workers
(e.g., technicians, registered nurses), and manual workers
(e.g., cleaners, maintenance workers), type of employ-
ment contract (permanent or fixed term) and type of
organization (municipality or hospital district).
Sleep apnoea as a predictor of work disability 1049The following comorbid conditions prevalent during the
year of the diagnosis of OSAS (i.e., 1994e2004) were
considered in this study: hypertension, ischemic heart
disease, diabetes, asthma or other chronic obstructive lung
disease and depression. In Finland, the national sickness
insurance scheme covers all permanent residents of the
country, regardless of sex, age or occupational title, and
provides at present basic reimbursement of 42% for all filled
prescriptions and special reimbursement of 72% or 100% for
many chronic and severe diseases. Patients who apply for
special reimbursement must attach a detailed medical
certificate prepared by the treating physician, who also
provides data to confirm the diagnosis. This is further
checked by a physician at the Social Insurance Institution
who reviews each case history. We extracted data on
entitlements of special reimbursements, i.e., rights to
receive higher than basic compensation for medication
costs of a serious chronic disease from the Drug Reim-
bursement Register, kept by the Social Insurance Institution
of Finland for hypertension, ischemic heart disease, dia-
betes and asthma or other chronic obstructive lung disease.
The presence of depression was determined by the use
of antidepressants. Data on the purchase of antidepres-
sants was derived from the Drug Prescription Register,
which comprises out-patient medication purchases clas-
sified according to the World Health Organization’s
Anatomical Therapeutic Chemical classification code.32
All the antidepressant purchases (ATC code N06A) and
corresponding defined daily doses (DDD) between 1994
and 2004 were extracted. Persons purchasing at least 100
DDD per year at baseline were considered as having
depression.
Outcome measures
Sickness absences
Data on sickness absences and related diagnoses were
obtained from the sickness absence register of the Social
Insurance Institution of Finland. All permanent residents
aged 16e67 years in Finland are entitled to daily allowances
due to a sick leave based on a medical certificate after
a waiting period of nine days, in addition to the first day of
illness, for a period of 1 year at themost. If theemployer pays
the salary during the sick leave, the reimbursement is given
to theemployer. The information retrieved from thenational
register for this study covers the dates of all reimbursed
sickness absences during 1994 and 2005.
For sick leaves lasting 90 days, the main diagnoses
were additionally retrieved. Four main disease categories
were used in this study: mental and behavioural diseases
(International Classification of Diseases, ICD-10: F00-F99);
diseases of circulatory system, (I00-I99); diseases of the
musculoskeletal system and connective tissue (M00-M99);
and injury, poisoning or other consequences of external
cause, (S00-T98). Diagnoses for sick leaves lasting 90 days
have been recorded for all cases from year 1997 onward,
but before that the information is available only for 10%
random sample of the population.
Disability pension
Data on work disability pension were obtained from the
Finnish Centre for Pensions, which provides a completeretirement data as it grants pensions for all permanent
residents in Finland. The dates and underlying causes
(according to the ICD-10) of early retirement were obtained
from medical certificates for all participants granted a full
disability pension between 1994 and 2005.
Statistical analyses
Since health care utilization has been shown to increase
when approaching the time of the OSAS diagnosis,26 we
included a one year post-diagnosis ‘‘wash-out’’ period and
started the follow-up 365 days after the date of diagnosis
for each OSAS case and at the same time for the corre-
sponding controls. The follow-up ceased at the end of 2005
or on the date of sickness absence or disability pension was
granted, or the person died or reached the age of 63 years
(statutory age of retirement). The mean time at risk was
5.9 (SD 3.0) years and 5.8 (SD 3.0) years for cases and
controls, respectively.
Cox proportional hazards models were used to estimate
the relative risk of the first work disability event between
cases and controls separately for men and women. The
time-dependent interaction between OSAS and follow-up
period was statistically non-significant confirming that the
proportional hazards assumption was justified.33 The
outcome variables were first sickness absence (>9 days),
first very long sickness absence (90 days), first full-time
disability pension and cause-specific work disability. For the
last outcome, very long sickness absences and disability
pension were considered together due to a fairly low
number of events in different diagnostic groups. Hazard
ratios (HR) and their 95% confidence intervals (CI) were
always adjusted for sociodemographic factors (age, gender,
SEP, type of employment contract and type of organiza-
tion), and additionally for the presence of baseline medical
conditions (chronic hypertension, ischemic heart disease,
diabetes, chronic asthma or other chronic obstructive lung
disease and depression). To further clarify the importance
of different comorbidities associated with OSAS as predic-
tors of future sickness absence or disability pension, we
divided the population into subgroups according to the
presence of major diseases associated with OSAS, i.e.,
cardiovascular diseases or diabetes, asthma or other
chronic obstructive lung diseases and depression at
baseline.
All statistical analyses were carried out using the SAS 9.1.3
programme package (SAS Institute Inc., Cary, NC, USA).
Results
A total of 766 cases (59.5% men) fulfilling all the pre-
determined inclusion criteria were detected from the
Hospital Discharge Register during 1994e2004. Baseline
characteristics of the employees with sleep apnoea (cases)
and their corresponding controls (nZ 3827) are shown in
Table 1. Sociodemographic characteristics did not differ
between the groups indicating the success of matching. As
expected, employees with OSAS had more comorbid
medical conditions than the controls. For example, 23.4% of
the cases had chronic hypertension, 8.6% chronic asthma or
other obstructive lung disease and 9.8% had depression.
1050 N. Sjo¨sten et al.The corresponding figures for controls were 10.2%, 3.0% and
2.2%, respectively. In total 38.8% of the sleep apnoea
patients had at least one comorbid condition, compared to
16.4% of controls.
Association between OSAS and sickness absences
Table 2 shows the associations between OSAS and all or
very long sickness absences by gender. For both outcomes,
OSAS was associated with an increased risk of sicknessTable 1 Baseline characteristics of employees with obstruc
(nZ 4593).
Employees with OS
n (%)
Gender
Men 456 (59.5)
Women 310 (40.5)
Age
e44 211 (27.6)
45e54 353 (46.1)
55e63 202 (26.4)
Socioeconomic class
Upper-grade non-manual workers 213 (27.8)
Lower-grade non-manual workers 261 (34.1)
Manual worker 292 (38.1)
Type of employment contract
Permanent 637 (83.2)
Fixed term 129 (16.8)
Type of organization
Municipality 628 (82.0)
Hospital district 138 (18.0)
Presence of severe or chronic illnessa
Yes 297 (38.8)
No 469 (61.2)
Chronic hypertension
Yes 179 (23.4)
No 587 (76.6)
Ischemic heart disease
Yes 24 (3.1)
No 742 (96.9)
Diabetes
Yes 21 (2.7)
No 745 (97.3)
Asthma or other chronic obstructive lung disease
Yes 66 (8.6)
No 700 (91.4)
Depression (100 DDDsb/year)
Yes 75 (9.8)
No 691 (90.2)
Differences between cases and controls in categorical variables were
a Granted special reimbursement for chronic hypertension, ischemic
disease or purchase of antidepressants (‡100 DDDs/year) according to
b DDDZ defined daily dose.absences in men and women and the risk was only partly
attributable to comorbidities. The hazard of the first
sickness absence period during the follow-up was 1.7e1.9
times higher for male and 2.1e2.0 times higher in female
sleep apnoea cases compared to controls when adjusted
for sociodemographic factors. The hazard ratios were
similar for very long-term sickness absences. After further
adjustments for different comorbidities the hazard ratios
attenuated by 9.9%e21.6% in men and 12.4%e23.1% in
women.tive sleep apnoea syndrome (OSAS) and control subjects
AS (nZ 766) Controls (nZ 3827) p-value
n (%)
2277 (59.5) 0.987
1550 (40.5)
1055 (27.6) 1.000
1765 (46.1)
1007 (26.3)
1065 (27.8) 1.000
1302 (34.0)
1460 (38.2)
3185 (83.2) 0.965
642 (16.8)
3140 (82.1) 0.966
687 (18.0)
629 (16.4) <0.0001
3198 (83.6)
389 (10.2) <0.0001
3438 (89.8)
54 (1.4) 0.001
3773 (98.6)
65 (1.7) 0.052
3762 (98.3)
114 (3.0) <0.0001
3713 (97.0)
85 (2.2) <0.0001
3742 (97.8)
tested by Chi-Square (c2) test.
heart disease, diabetes, asthma or other chronic obstructive lung
the register of the Social Insurance Institution of Finland.
Table 2 Hazard ratios (HR) and 95% confidence intervals (CIs) for all (>9 days) and very long (90 days) sickness absence
periods and disability pension in men and women by sleep apnoea status.
n No. of events HR (95% CI) HR (95% CI)
Model 1a Model 2b
All sickness absences (>9 days)
Men
No OSAS 2277 1003 1.0 1.0
OSAS 456 267 1.7 (1.5e2.0) 1.6 (1.4e1.9)
Women
No OSAS 1550 660 1.0 1.0
OSAS 310 192 2.1 (1.8e2.4) 1.9 (1.6e2.3)
Very long sickness absences (90 days)
Men
No OSAS 2277 278 1.0 1.0
OSAS 456 97 1.9 (1.5e2.4) 1.7 (1.3e2.1)
Women
No OSAS 1550 156 1.0 1.0
OSAS 310 58 2.0 (1.5e2.8) 1.8 (1.3e2.5)
Disability pension
Men
No OSAS 2277 179 1.0 1.0
OSAS 456 78 2.2 (1.7e2.9) 1.9 (1.5e2.6)
Women
No OSAS 1550 109 1.0 1.0
OSAS 310 56 2.7 (1.9e3.7) 2.1 (1.5e3.0)
OSASZ obstructive sleep apnoea syndrome.
a Adjusted for age, socioeconomic position, type of employment contract, type of organization.
b Adjusted for (a) and presence of comorbid conditions (chronic hypertension, ischemic heart disease, diabetes and asthma or other
chronic obstructive lung disease and depression).
Sleep apnoea as a predictor of work disability 1051Association between OSAS and disability pension
There was also a statistically significant association
between OSAS and full-time disability pension (Table 2).
The Cox proportional hazards models adjusted for socio-
demographic factors showed an approximately 2.2- and
2.7-fold increase in the risk for disability pension in men
and women with OSAS, respectively. The estimates
decreased in the fully adjusted model, however, still
remaining approximately 2-folds in both genders.
Comorbidity
Fig. 1 shows the percentage of employees who were gran-
ted a disability pension during the follow-up, by the status
of comorbidity and coexisting OSAS. Persons with OSAS but
no comorbidities and those with cardiovascular disease or
diabetes and coexisting OSAS had an approximately 2-fold
risk for subsequent disability pension compared to the
corresponding control group with no OSAS. Further adjust-
ments attenuated the hazard ratios by 15.4%e22.2%.
Similar results were found with regard to sickness absences.
Employees with OSAS but no comorbidities and those with
cardiovascular disease, diabetes or asthma and coexisting
OSAS had an increased risk for sickness absences compared
to employees with no OSAS when adjusted for all cova-
riates. Among persons with depression, no excess risk wasfound in terms of subsequent sickness absence or disability
pension, but the number of cases was small.
Association between OSAS and cause-specific work
disability
Table 3 shows the results of the association between OSAS
and a composite outcome of subsequent very long sickness
absence and disability pension according to the major
diagnostic categories. Employees with OSAS had an
increased risk of work disability in all diagnostic categories,
but a particularly high risk for work disability caused by
different injuries and mental disorders (HR in the fully
adjusted model 3.1, 95% CI: 1.8e5.2 and 2.8, 95% CI: 2.1e
3.7, respectively).
Discussion
In this large register-based study on Finnish public sector
employees, OSAS was associated with a 1.7e2.7-fold excess
risk of work disability in men and women during approxi-
mately six years after the OSAS diagnosis. These associa-
tions were observed for various indicators of work
disability, including total sickness absence, long-term
absence and disability pensions and they remained statis-
tically significant after adjustments for comorbid medical
conditions. Intriguingly, the risk was constantly more
05
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AsthmaNo asthmaCVD/DMNo CVD/DMDepressionNo depression
15
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1.0 
1.0 
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(1.5-3.2)  
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(1.9-2.9)  
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(0.9-3.9) 
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Figure 1 Risk of work disability by status of obstructive sleep apnoea syndrome (OSAS) and coexisting chronic diseases at
baseline. The figure gives percentage of employees granted disability pension during the follow-up and corresponding hazard ratios
and their 95% confidence intervals. Chronic diseases were defined according to the registers of the Social Insurance Institution of
Finland. Adjusted for age gender, socioeconomic position, type of employment contract and type of organization. CVDZ car-
diovascular diseases (hypertension, ischemic heart disease); DMZ diabetes mellitus; and asthmaZ chronic asthma or other
chronic obstructive lung disease. No. of cases and controls in each group: no depression nZ 691 and nZ 3742; depression nZ 75
and nZ 85; no CVD/DM nZ 565 and nZ 3370; CVD/DM nZ 201 and nZ 457; no asthma nZ 700 and nZ 3713; asthma nZ 66 and
nZ 114, respectively.
1052 N. Sjo¨sten et al.pronounced among women than among men. With regard to
cause-specific work disability, employees with OSAS had
a particularly high risk of work disability caused by
different injuries and mental disorders.
Our study is among the first in directly assessing the risk
of sickness absence and disability pension among personsTable 3 Risk of cause-specific work disability (long-term sick
quantified as Hazard Ratios (HR) and 95% confidence intervals (C
Cause of work disability n No. of e
Mental and behavioural disorders
No OSAS 3827 122
OSAS 766 72
Diseases of the musculoskeletal
system and connective tissue
No OSAS 3827 215
OSAS 766 72
Diseases of circulatory system
No OSAS 3827 56
OSAS 766 25
Injury, poisoning and certain other
consequences of external causes
No OSAS 3827 39
OSAS 766 22
OSASZ obstructive sleep apnoea syndrome.
a Adjusted for age, gender, socioeconomic status, type of employm
b Adjusted for (a) and presence of physical illnesses (chronic hype
chronic obstructive lung disease).
c Adjusted for (a) and presence of comorbid conditions (chronic hyp
chronic obstructive lung disease and depression).
d Adjusted for (a) and presence of asthma or other chronic obstructwith diagnosed OSAS. Recently self-reported symptoms of
OSAS were also associated with long-term sickness leave
and permanent work disability.29 Since we were able to use
properly diagnosed patients, our study is less prone to
reporting bias. Therefore, it notably adds to the existing
evidence on the association between sleep apnoea andness absences or disability pension) by sleep apnoea status
Is).
vents HR (95% CI) HR (95% CI)
Model 1a Model 2b
1.0 1.0
2.9 (2.2e3.9) 2.8 (2.1e3.7)b
1.0 1.0
1.6 (1.2e2.1) 1.5 (1.2e2.0)c
1.0 1.0
2.1 (1.3e3.3) 2.1 (1.3e3.4)d
1.0 1.0
2.8 (1.6e4.7) 3.1 (1.8e5.2)c
ent contract, and type of organization.
rtension, ischemic heart disease, diabetes and asthma or other
ertension, ischemic heart disease, diabetes and asthma or other
ive lung disease and depression.
Sleep apnoea as a predictor of work disability 1053long-term work disability. Indirect evidence from previous
studies is also consistent with our findings as OSAS or its
symptoms have been associated with an increased risk for
occupational and leisure time accidents21,34,35 and an
increased utilization of health care services,16,19,25e28 even
10 years before the actual diagnosis.26 Also fatigue has
predicted intermediate and long-term sickness absences in
the general population.36
In the present study, almost 40% of employees with
OSAS also had some other chronic disease (cardiovascular
disease, diabetes, asthma or other chronic obstructive
lung disease or depression). Since such chronic diseases
are major risk factors for work disability,37e40 the excess
risk of work disability related to OSAS could be attribut-
able to these comorbid conditions. According to our
results the hazard ratios of work disability attenuated by
9.9%e32.1% after adjustments for different comorbid-
ities, but still remained at statistically significantly
elevated levels compared to controls. The excess risk was
thus only partly attributable to other severe and chronic
diseases.
Patient group analyses provided further support for the
status of OSAS as an independent risk factor of work
disability. Among employees with medical comorbidity,
coexisting OSAS was associated with an increased risk for
subsequent sickness absences and disability pension.
Although these results were based on a selective small
number of cases, they indicate that OSAS per se increases
the risk of work disability, even among persons with other
severe and chronic diseases. Among employees with
depression and coexisting OSAS, the risk estimates were
notably lower and statistically non-significant. This may
indicate that among employees with depression, OSAS does
not predispose to any further risk of work disability.
However, we may have misclassified some depression
cases, because antidepressant use as a proxy measure lacks
sensitivity, i.e., cases without antidepressant treatment
are not detected. In addition, depression per se is one of
the major risk factors of very long work absenteeism41,42
and has often been linked to OSAS.43 It has been suggested
that among sleep apnoea patients depression could be
considered as secondary to the medical disorder rather
than a distinct psychiatric entity.44
Prospective study design and large sample size are
important strengths of this study. The data for this study
were obtained from national registers, which are reliable
and have high coverage.45,46 All medically certified long-
term sickness absences were retrieved from the Social
Insurance Institution of Finland, which is a responsible
organ for execution of statutory health insurance covering
basically all citizens residing in Finland. To detect sleep
apnoea cases the national Hospital Discharge Register was
used. The use of this kind of register information minimizes
the risks of measurement and recall bias, often associated
with self-reported measures.47
There are, however, some limitations to be considered
when interpreting the results of our study. First, some
misclassification of OSAS is possible. Only persons who
were discharged from hospital with the main diagnosis of
OSAS according to the Hospital Discharge Register for the
first time during 1994e2004 were included in this study as
cases. Some kind of sleep registration was very likelyduring their stay, even though we were not able to verify
this. Since all patients had spent at least one night in
hospital, we assume that the cases included in this study
are most probably ‘‘certain’’ cases, i.e., true sleep
apnoea patients. We believe thus that our measure had
a high specificity. In contrast, our measure may lack
sensitivity; we were probably able to reach only the ‘‘tip
of the iceberg’’. It is estimated that even one in five
adults has asymptomatic or nearly asymptomatic sleep
apnoea5 and many of these remain undiagnosed.48,49
However, in the present study the effect of false nega-
tives is diluted into a large amount of healthy controls,
and do not thus bias the results. Furthermore, misclassi-
fication due to false negatives is likely to cause a large
bias in estimation only if the prevalence of the disease is
high and the effect very large. In the present study,
a roughly estimated lifetime prevalence of OSAS was 0.5%
among female and 2.2% among male employees in our
cohort. These estimates are close to the Finnish national
estimates discovered in the Health 2000 survey, where
the prevalence of diagnosed OSAS was 0.4% in women,
2.4% in men.50
Second, Body Mass Index (BMI) could not be taken into
account in matching or in the analyses due to unavailability
of this data from registers. High BMI has predicted tempo-
rary and long-term work disability51,52 and obesity has been
shown to predispose people with OSAS to higher health
service utilization.26 However, in our sample only 19
participants had a diagnosis of obesity suggesting that
overweight, at least in its severest form, was not common.
In addition, we were unable to control for stressful work
characteristics, such as long working hours, high work load
and low job control, which have previously been associated
with disability pension.53
Third, we do not know, whether our participants with
OSAS were effectively treated after the diagnosis or not,
and whether they adhered to the treatment if determined.
Previously, treatment of OSAS with continuous positive
airway pressure (CPAP) has reduced health care utilization
and costs during five years after the diagnosis.27 The effect
of different treatment modalities on temporary and
permanent work disability should be considered in further
studies.
Finally, this is a prospective follow-up study of public
sector employees and is, therefore, not representative of
the Finnish working population, which potentially limits the
generalisability of our findings.
In conclusion, our results indicate that OSAS may seri-
ously deteriorate working ability by increasing the risk of
both sickness absences and full-time disability pension
among employees with OSAS. These results emphasize the
need to identify the employees with this disorder and to
improve general practitioners’ knowledge about screening
of OSAS symptoms and indicators.Conflict of interest statement
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